logo

US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy

By: theblockbeats.news|2025/08/04 13:02:14

BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.


This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.

The Ether Machine has announced an increase in holdings of 10,605 ETH, bringing the total holdings to 345,362 ETH.
US Stock DFDV Announces Increase in Holding of 110,000 SOL, Bringing Total Holdings to 1,293,000 SOL

You may also like

Share
copy

Gainers

Latest Crypto News

04:15

The Wise Investor invested $179,800 in PIPPIN one month ago, and now has an unrealized gain of $1,350,000.

04:15

「HYPE Listing Insider Whale」's 5x HYPE Long Position is currently at a $10.87 million unrealized loss

04:15

Opinion: While the current round of quantitative tightening in the U.S. is set to conclude today, its related effects may not be felt until early next year

04:15

Rayls Tokenomics Release: TGE to Distribute 15% of Tokens

04:15

Japan's 2-Year Government Bond Yield Rises to 1%, Hits New High Since 2008

Read more
Community
icon
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MM[email protected]

VIP Services[email protected]